title: Deep vein thrombosis: how long will it remain?
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Asakura
authors.forename: Hiroki
authors.initials: H
authors.lastname: Tsuchiya
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Nieda
authors.forename: Takashi
authors.initials: T
authors.lastname: Yano
authors.forename: Tadashi
authors.initials: T
authors.lastname: Kato
authors.forename: Hideki
authors.initials: H
authors.lastname: Takagi
mesh_terms: D000368:Aged; D000768:Anesthesia, General; D000991:Antithrombins / Q000627:therapeutic use; D019645:Arthroplasty, Replacement, Knee; D005260:Female; D000077425:Fondaparinux; D006801:Humans; D048228:Intermittent Pneumatic Compression Devices; D011134:Polysaccharides / Q000627:therapeutic use; D011183:Postoperative Complications / Q000628:therapy*; D014111:Tourniquets; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*
chemical_list: D000991:Antithrombins; D011134:Polysaccharides; D000077425:Fondaparinux